Alpha DNA Investment Management »

United Therapeutics Corporation shares owned by Alpha DNA Investment Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Alpha DNA Investment Management from 13F filings

Historical chart of Alpha DNA Investment Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Alpha DNA Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $750k 2.1k 358.35
2024-06-30 $966k 3.0k 318.55

More positions owned by Alpha DNA Investment Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Wal-Mart Stores (WMT)
Apple (AAPL)
Bank of America Corporation (BAC)
JPMorgan Chase & Co. (JPM)
Nextera Energy (NEE)
Honeywell International (HON)
Microsoft Corporation (MSFT)
Verizon Communications Call Option (VZ)
Philip Morris International (PM)
Arista Networks (ANET)
Abbvie (ABBV)
Chubb (CB)
Texas Instruments Incorporated (TXN)

View all positions for Alpha DNA Investment Management

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation